A systematic approach for developing bacteria-specific imaging tracers

Journal of Nuclear Medicine

Volumn 58, Issue 1, 2017, Pages 144-150

  Ordonez, Alvaro A ^a   Weinstein, Edward A ^a   Bambarger, Lauren E ^a   Saini, Vikram ^a   Chang, Yong S ^a   DeMarco, Vincent P ^a   Klunk, Mariah H ^a   Urbanowski, Michael E ^a   Moulton, Kimberly L ^a   Murawski, Allison M ^a   Pokkali, Supriya ^a   Kalinda, Alvin S ^a   Jain, Sanjay K ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bacteria; Drug resistance; Imaging; PET; Translational

Indexed keywords

4 AMINOBENZOIC ACID; CARBAPENEM; FLUORODEOXYGLUCOSE F 18; MANNITOL; SORBITOL; TRACER; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL INFECTION; BACTERIAL STRAIN; CONTROLLED STUDY; DIAGNOSTIC IMAGING; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTION; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; FEMALE; IMAGING SYSTEM; IN VITRO STUDY; INFECTION SENSITIVITY; ISOTOPE LABELING; MAMMAL CELL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MOUSE; MYCOBACTERIUM TUBERCULOSIS; MYOSITIS; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; TREATMENT RESPONSE; BACTERIUM; CLASSIFICATION; CYTOLOGY; METABOLISM; MICROBIOLOGY; PROCEDURES; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

4-AMINOBENZOIC ACID; BACTERIA; BACTERIAL INFECTIONS; ISOTOPE LABELING; MANNITOL; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SORBITOL;

EID: 85009083891     PISSN: 01615505     EISSN: 2159662X     Source Type: Journal    
DOI: 10.2967/jnumed.116.181792     Document Type: Article

References (30)

1. Mac Faddin JF. Biochemical Tests for Identification of Medical Bacteria. Baltimore, MD: The Williams & Wilkins Company; 1976.
2. Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013;41:580-637.
3. Li ZB, Wu Z, Cao Q, et al. The synthesis of 18F-FDS and its potential application in molecular imaging. Mol Imaging Biol. 2008;10:92-98.
4. Weinstein EA, Ordonez AA, DeMarco VP, et al. Imaging Enterobacteriaceae infection in vivo with 18F-fluorodeoxysorbitol positron emission tomography. Sci Transl Med. 2014;6:259ra146.
5. Sievers F, Wilm A, Dineen D, et al. Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol. 2011;7:539.
6. Doherty GJ, McMahon HT. Mechanisms of endocytosis. Annu Rev Biochem. 2009;78:857-902.
7. Zuluaga AF, Salazar BE, Rodriguez CA, Zapata AX, Agudelo M, Vesga O. Neutropenia induced in outbred mice by a simplified low-dose cyclophosphamide regimen: characterization and applicability to diverse experimental models of infectious diseases. BMC Infect Dis. 2006;6:55.
8. Bates DW, Sands K, Miller E, et al. Predicting bacteremia in patients with sepsis syndrome. Academic Medical Center Consortium Sepsis Project Working Group. J Infect Dis. 1997;176:1538-1551.
9. Scott RD. The direct medical costs of healthcare-Associated infections in U.S. hospitals and the benefits of prevention. CDC website. http://www.cdc.gov/hai/pdfs/hai/scott-costpaper.pdf. Accessed October 6, 2016.
10. Gemmel F, Dumarey N, Welling M. Future diagnostic agents. Semin Nucl Med. 2009;39:11-26.
11. van Oosten M, Hahn M, Crane LM, et al. Targeted imaging of bacterial infections: Advances, hurdles and hopes. FEMS Microbiol Rev. 2015;39:892-916.
12. Vinjamuri S, Hall AV, Solanki KK, et al. Comparison of 99mTc infection imaging with radiolabelled white-cell imaging in the evaluation of bacterial infection. Lancet. 1996;347:233-235.
13. Sarda L, Cremieux AC, Lebellec Y, et al. Inability of 99mTc-ciprofloxacin scintigraphy to discriminate between septic and sterile osteoarticular diseases. J Nucl Med. 2003;44:920-926.
14. Palestro C, Love C, Caprioli R, et al. Phase II study of 99mTc-ciprofloxacin uptake in patients with high suspicion of osteomyelitis [abstract] J Nucl Med. 2006;47:152P.
15. Ebenhan T, Zeevaart JR, Venter JD, et al. Preclinical evaluation of 68Ga-labeled 1, 4, 7-Triazacyclononane-1, 4, 7-Triacetic acid-ubiquicidin as a radioligand for PET infection imaging. J Nucl Med. 2014;55:308-314.
16. Vilche M, Reyes AL, Vasilskis E, Oliver P, Balter H, Engler H. 68Ga-NOTAUBI-29-41 as a PET tracer for detection of bacterial infection. J Nucl Med. 2016;57:622-627.
17. Welling M, Stokkel M, Balter J, Sarda-Mantel L, Meulemans A, Le Guludec D. The many roads to infection imaging. Eur J Nucl Med Mol Imaging. 2008; 35:848-849.
18. Bettegowda C, Foss CA, Cheong I, et al. Imaging bacterial infections with radiolabeled 1-(29-deoxy-29-fluoro-beta-D-Arabinofuranosyl)-5-iodouracil. Proc Natl Acad Sci USA. 2005;102:1145-1150.
19. Zhang XM, Zhang HH, McLeroth P, et al. [124I]FIAU: human dosimetry and infection imaging in patients with suspected prosthetic joint infection. Nucl Med Biol. 2016;43:273-279.
20. Gowrishankar G, Namavari M, Jouannot EB, et al. Investigation of 6-[18F]-fluoromaltose as a novel PET tracer for imaging bacterial infection. PLoS One. 2014;9:e107951.
21. Ning X, Seo W, Lee S, et al. PET imaging of bacterial infections with fluorine-18-labeled maltohexaose. Angew Chem Int Ed Engl. 2014;53:14096-14101.
22. Wiehr S, Warnke P, Rolle AM, et al. New pathogen-specific immunoPET/MR tracer for molecular imaging of a systemic bacterial infection. Oncotarget. 2016;7:10990-11001.
23. Johansson G, Bingham S, Vahter M. A method to compensate for incomplete 24-hour urine collections in nutritional epidemiology studies. Public Health Nutr. 1999;2:587-591.
24. Brown GM. The biosynthesis of folic acid: II-inhibition by sulfonamides. J Biol Chem. 1962;237:536-540.
25. Lengeler J. Nature and properties of hexitol transport systems in Escherichia coli. J Bacteriol. 1975;124:39-47.
26. Figge RM, Ramseier TM, Saier MH Jr. The mannitol repressor (MtlR) of Escherichia coli. J Bacteriol. 1994;176:840-847.
27. Ordonez AA, Tasneen R, Pokkali S, et al. Mouse model of pulmonary cavitary tuberculosis and expression of matrix metalloproteinase-9. Dis Model Mech. 2016;9:779-788.
28. Murawski AM, Gurbani S, Harper JS, et al. Imaging the evolution of reactivation pulmonary tuberculosis in mice using 18F-FDG PET. J Nucl Med. 2014;55:1726-1729.
29. Wakabayashi H, Werner RA, Hayakawa N, et al. Initial preclinical evaluation of 18F-fluorodeoxysorbitol PET as a novel functional renal imaging agent. J Nucl Med. 2016;57:1625-1628.
30. Zhu W, Yao S, Xing H, et al. Biodistribution and radiation dosimetry of the Enterobacteriaceae-specific imaging probe [18F]fluorodeoxysorbitol determined by PET/CT in healthy human volunteers. Mol Imaging Biol. 2016;5:782-787.